- Home
- App Analytics
- eScription One
- eScription One Vs. iTransfuse
eScription One vs iTransfuse Usage & Stats
eScription One allows authorized clinicians to create and manage high quality documentation for an EMR with minimal time and effort. Clinicians dictate the narrative and keep pace with busy patient loads without compromising time with patients, revenue potential or length of workday. Meanwhile, timely, complete, structured data in the EMR reduces claim rejections, decreases time to bill and enhances compliance.
A real-time schedule feed serves as a daily work list while access to patient demographics and history informs dictations. System-generated dictation templates – personalized by each clinician – streamline document creation by requiring only exceptions be dictated. Transcribed content is easily reviewed, edited and signed. Upon completion, uploaded files are automatically integrated into the EMR, faxed, or printed.
REQUIREMENTS:
* iOS 15.2 or greater
* Internet access through Wifi or phone service provider is required. WiFi connection is strongly recommended when uploading dictations.
* An account is required to use this application.
FEATURES AND BENEFITS:
* Manage the documentation task with less time and effort. Clinicians organize documentation tasks across multiple devices by viewing all appointments with dictation status or only appointments still requiring dictation. A list of returned transcriptions allows clinicians to advance quickly through the review and authentication process.
* Improve documentation quality. Save time and remove risk when patient data, demographics and appointment location are automatically linked to the voice file and available for easy reference while dictating.
* Customize workflow to meet clinic needs. Flexible application settings easily accommodate the unique, complex workflow requirements of specialty practices.
* Delegate transcription and QA to support staff. Completed dictations upload in the background and are automatically routed to a professional medical transcriptionist to produce a typed report that is automatically returned for review.
* Increase clinician productivity and satisfaction. A library of templates—customizable for each clinician—automatically populates common content as editable text, speeding dictation.
* Speed documentation turnaround. Real-time file upload, download and routing ensures prompt dictation, transcription, editing, authentication and accessibility in the EMR.
* Populate the EMR automatically. Sophisticated integration generates structured data automatically placed in the EMR, improving EMR usability and boosting adoption and ROI.
* Enhance the patient experience By completing documentation on mobile devices, providers are free to engage with patients rather than computer screens during exams.
* Control documentation costs All-inclusive solution components require no server hardware or infrastructure, eliminating all upfront fees. Unlimited client support, updates and maintenance included at no additional cost.
WHAT CLIENTS ARE SAYING:
“When we introduced our physicians to Emdat Mobile, all of them were amazed by how easy it made their dictation and improved their workflow; and they wanted it right away.”
— William Whelehan, Purchasing Director, Illinois Bone & Joint Institute
- Apple App Store
- Free
- Medical
Store Rank
- -
The iTransfuse App promotes safe, appropriate and evidence-based transfusion by providing bedside access to transfusion education tools and resources. It includes information to support the prescription of red cells and platelets, diagnostic information about transfusion reactions, and much more.
- Apple App Store
- Free
- Medical
Store Rank
- -
eScription One vs. iTransfuse ranking comparison
Compare eScription One ranking trend in the past 28 days vs. iTransfuse
Rank
No Data Available
eScription One vs. iTransfuse ranking by country comparison
Compare eScription One ranking trend in the past 28 days vs. iTransfuse
No Data to Display
Compare to any site with our free trial
eScription One VS.
iTransfuse
December 14, 2024